Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.

@article{Scaringi2008AdvancedGC,
  title={Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.},
  author={Stefano Scaringi and R{\'e}za Kianmanesh and J M Sabat{\'e} and Enrico Facchiano and Pauline Jouet and Beno{\^i}t Coffin and Gilles Parmentier and Jean Marie Hay and Yves Flamant and Simon Msika},
  journal={European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
  year={2008},
  volume={34 11},
  pages={1246-52}
}
INTRODUCTION The aim of this article was to evaluate the role of hyperthermic intraperitoneal chemotherapy (HIPEC), associated or not to cytoreductive surgery (CS) in the treatment of different stages of advanced gastric cancer (AGC). PATIENTS AND METHODS Thirty seven patients with AGC who underwent 43 HIPEC from June 1992 to February 2007 were included. HIPEC used Mitomycin-C and Cisplatin for 60-90 min at 41-43 degrees C intra-abdominal temperature. The main endpoints were long-term… CONTINUE READING